Genedata AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Genedata AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10327
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, genedata screener, genedata expressionist, genedata philosopher, genedata analyst and genedata selector. Genedata provides services such as information technology services, data analysis, custom software development, training, and hosting. The company also offers support and training services. It serves pharma, bio-pharma, agribusiness, industrial biotech, food and beverage, and other sectors. The company has presence in Switzerland, Germany, the US and Japan. Genedata is headquartered in Basel, Switzerland.

Genedata AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genedata AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genedata AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Genedata AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genedata AG, Medical Equipment, Deal Details 10
Partnerships 10
AstraZeneca Enters into Agreement with Genedata 10
Kymab Enters into Licensing Agreement with Genedata 11
Genedata Enters into Integration Agreement with IntelliCyt 12
Genedata Enters into Co-Development Agreement with Bayer Pharma 13
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 14
Genedata Enters Into Technology Integration Agreement With Insilico Biotechnology 15
Ono Pharma Extends its Licensing Agreement with Genedata 16
Genedata AG – Key Competitors 17
Genedata AG – Key Employees 18
Genedata AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Dec 12, 2017: Genedata and Titian Collaborate to Deliver Seamless Flow from Sample Inventory to Data Analysis 20
Feb 21, 2017: Genedata Expands Into United Kingdom 21
Product News 22
Oct 16, 2018: Deep learning-based Genedata Imagence for automated high-content image analysis debuts at SLAS Conference 22
Feb 21, 2018: Genedata Profiler 11.0 Automates Biomarker Identification for Optimizing Clinical Trial Patient Selection 24
Feb 02, 2018: Genedata Profiler Powers Major Breakthroughs in Early Prediction of Breast and Ovarian Cancer 25
Other Significant Developments 26
May 15, 2018: Bio-IT World Conference Sessions Present Cloud-Deployed Genedata Screener as Integral to Biotech R&D Infrastructure 26
Feb 06, 2018: Genedata Announces New Solution for NGS-Based Biosafety Assessment 28
Feb 06, 2017: Genedata Announces BMG LABTECH, Creoptix and TTP Labtech as New Ready-to-Run Partners 29
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Genedata AG, Medical Equipment, Key Facts 2
Genedata AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Genedata AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genedata AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Deals By Market, 2012 to YTD 2018 8
Genedata AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AstraZeneca Enters into Agreement with Genedata 10
Kymab Enters into Licensing Agreement with Genedata 11
Genedata Enters into Integration Agreement with IntelliCyt 12
Genedata Enters into Co-Development Agreement with Bayer Pharma 13
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 14
Genedata Enters Into Technology Integration Agreement With Insilico Biotechnology 15
Ono Pharma Extends its Licensing Agreement with Genedata 16
Genedata AG, Key Competitors 17
Genedata AG, Key Employees 18
Genedata AG, Subsidiaries 19

List of Figures
Genedata AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Genedata AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Genedata AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Genedata AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Genedata AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genedata AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Genedata AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genedata AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Genedata AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NBCUniversal Media LLC:企業のM&A・事業提携・投資動向
    NBCUniversal Media LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NBCUniversal Media LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • SHV Holdings N.V.:企業の戦略・SWOT・財務情報
    SHV Holdings N.V. - Strategy, SWOT and Corporate Finance Report Summary SHV Holdings N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EarLens Corp:医療機器:M&Aディール及び事業提携情報
    Summary EarLens Corp (EarLens) is engaged in designing and manufacturing of hearing aid products for hearing impaired patients. Its lead product Earlens Hearing Aid is a hearing device that utilizes light to transmit sound. The device automatically adjusts to noisy environments and delivers the broa …
  • Vectren Corp (VVC):企業の財務・戦略的SWOT分析
    Vectren Corp (VVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Mediware Information Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mediware Information Systems Inc (Mediware) is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solutions are equipped in blood banks …
  • Craneware plc (CRW):企業の財務・戦略的SWOT分析
    Summary Craneware plc (Craneware) is a healthcare technology company that provides revenue integrity solutions. The company provides patient engagement, charge capture and pricing; coding integrity, and revenue recovery and retention products, chargemaster tool kit, online reference tool kit, physic …
  • Tenaga Nasional Bhd (TENAGA):電力:M&Aディール及び事業提携情報
    Summary Tenaga Nasional Bhd (TNB) is an electricity utility that generates, transmits, distributes and supplies power. It develops, operates and maintains a portfolio of power generating units. The company produces electricity from crude oil, natural gas, hydro, coal and gas sources. TNB also suppli …
  • Sectra AB (SECT B):企業の財務・戦略的SWOT分析
    Sectra AB (SECT B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • DiaGenic ASA (NEL)-製薬・医療分野:企業M&A・提携分析
    Summary DiaGenic ASA (DiaGenic) is a medical device company that develops innovative in vitro diagnostic products for early detection of diseases. The company specializes in developing blood-based biomarkers. Its ADtect product is a blood test that helps distinguish mild to moderate range AD from th …
  • BelAZ:企業の戦略・SWOT・財務情報
    BelAZ - Strategy, SWOT and Corporate Finance Report Summary BelAZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Roche Diagnostics Corp:企業のM&A・事業提携・投資動向
    Roche Diagnostics Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Roche Diagnostics Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • TherOx Inc:医療機器:M&Aディール及び事業提携情報
    Summary TherOx Inc (TherOx) is a medical device company that develops and commercializes SuperSaturated Oxygen (SSO2) therapies for treatment of heart attack. Its SSO2 therapy is designed to ameliorate progressive myocardial necrosis by minimizing microvascular damage in heart attack patients. TherO …
  • APR Energy Ltd:電力:M&Aディール及び事業提携情報
    Summary APR Energy Ltd (APR), formerly APR Energy plc, is an energy solutions and services provider. The company installs, owns, operates and maintains power plants for applications such as bridging power, distributed power, grid stability and support, emergency power, industrial generation and peak …
  • Ceska rafinerska, a.s.-石油・ガス分野:企業M&A・提携分析
    Summary Ceska rafinerska, a.s. (Ceska rafinerska) is a crude oil refining company. It carries out the refining of crude oil, and production of petroleum based products. The company’s product portfolio includes automobile gasoline, diesel oil, aviation fuel, fuel oils, liquefied petroleum gas, heatin …
  • InspireMD Inc (NSPR):企業の財務・戦略的SWOT分析
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • AGILeBiotics BV:製薬・医療:M&Aディール及び事業提携情報
    Summary AGILeBiotics BV (AGILeBiotics) is a pharmaceutical company that focus on the discovery and development of new antibiotics to treat multi-drug resistant infections. The company’s patented synthetic method technology OxaSelect transforms the currently available antibiotics, which became less e …
  • Tom N Toms Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Rexnord Corp (RXN):電力:M&Aディール及び事業提携情報
    Summary Rexnord Corp (Rexnord) offers process and motion control, and water management products. The company designs, manufactures, markets and services mechanical components, and water flow control and conservation products. Its product portfolio includes motion control products, aerospace componen …
  • Terumo Corporation:企業の戦略・SWOT・財務情報
    Terumo Corporation - Strategy, SWOT and Corporate Finance Report Summary Terumo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cerner Corp (CERN)-医療機器分野:企業M&A・提携分析
    Summary Cerner Corp (Cerner) is a provider of healthcare information technology and related services. It offers a comprehensive range of solutions and services which assist the clinical, financial and operational needs of organizations. The company’s major solutions include extended care solutions; …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆